despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. . print . . . .
marketwatch: "new migraine drugs have promise -- and a ,500 price tag."
OFF DEAL
218 Used Today
OFF DEAL
OFF DEAL
200 Used Today